Research and Markets has announced the addition of the "Delta Like Protein 4 (Delta Like Ligand 4 or Drosophila Delta Homolog 4 or DLL4) - Pipeline Review, H2 2016" report to their offering.
Delta Like Protein 4 (Delta Like Ligand 4 or Drosophila Delta Homolog 4 or DLL4) Delta like ligand 4 (DLL4) is a member of the Delta family of Notch ligands. Delta like ligand 4 is a protein encoded by DLL4 gene. High selective expression pattern of DLL4 is found within the vascular endothelium. DLL4 is upregulated by hypoxia and vascular endothelial growth factor-A (VEGF-A). DLL4 plays a fundamental role in pathological angiogenesis, as blockers of the Dll4 Notch pathway result in decreased tumor growth.
Delta Like Protein 4 (Delta Like Ligand 4 or Drosophila Delta Homolog 4 or DLL4) pipeline Target constitutes close to 6 molecules. Out of which approximately 6 molecules are developed by Companies. The molecules developed by Companies in Phase II, Phase I, Preclinical and Discovery stages are 1, 2, 1 and 2 respectively.
Delta Like Protein 4 - Pipeline Review, H2 2016, outlays comprehensive information on the Delta Like Protein 4 (Delta Like Ligand 4 or Drosophila Delta Homolog 4 or DLL4) targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type.
It also reviews key players involved in Delta Like Protein 4 (Delta Like Ligand 4 or Drosophila Delta Homolog 4 or DLL4) targeted therapeutics development, features dormant and discontinued projects and latest news and press releases.
Key Topics Covered:
For more information about this report visit http://www.researchandmarkets.com/research/8svdq4/delta_like
View source version on businesswire.com: http://www.businesswire.com/news/home/20161017005737/en/Business Wire
Last updated on: 17/10/2016
PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.